Update on autoantibodies and related biomarkers in autoimmun... : Current Opinion in
Rheumatology Update on autoantibodies and related biomarkers in autoimmune inflammatory …

Histopathological analysis stands as the gold standard for the identification and
differentiation of inflammatory neuromuscular diseases. These disorders continue to …

The authors identified different pitfalls in the criteria and suggested actions that a possible
revision should take to overa come them. The focus is surely well directed, but we believe …

Objective Anti‐synthetase syndrome (ASSD) is a rare systemic autoimmune rheumatic
disease (SARD) with significant heterogeneity and no shared classification criteria. We …

Autoantibodies are important for the diagnosis of autoimmune interstitial lung disease (ILD).
Standard immunoassays have limitations, including their qualitative nature and/or a narrow …

Background: The usefulness of myositis-specific autoantibodies (MSAs) and myositis-
associated autoantibodies (MAAs) for the assessment of idiopathic inflammatory myopathies …

Myositis autoantibodies are widely accepted as important clinical tools, and hence, there is a
significant demand for reliable, accessible, and affordable detection methods. False …

A high prevalence of antinuclear antibodies (ANA) in COVID-19 has been insinuated, but
the nature of the target antigens is poorly understood. We studied ANA by indirect …

The evolution of classification of the idiopathic inflammatory myopathies (IIM) is fueled by
myositis-specific antibodies (MSA), clinicopathological features, and discoveries in the “ …

The rheumatic diseases are a diverse group of conditions that can display autoantibody
production, functional immune disturbances and systemic disease manifestations. These …